The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global blood glucose test strips market reached a value of US$ 10.53 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 17.57 Billion by 2027, exhibiting a CAGR of 8.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Blood glucose test strips refer to small, disposable plastic or paper strips used to monitor blood glucose levels and control diabetes symptoms. They are manufactured using polyolefin, polyamide, polysulfone and cellulose materials. A blood glucose test strip comprises several components, such as hydrophilic, adhesive, sensors, enzymes and electrode layers. They are also soaked in glucose oxidase that reacts with glucose present in the blood sample to indicate sugar levels. Apart from this, blood glucose test strips are easy to use, cost-effective, and can be used daily. Consequently, they assist in identifying high or low blood sugar levels, monitoring the effectiveness of diabetes treatment, and lowering the risks of developing hypoglycemia and/or hyperglycemia.
The increasing prevalence of diabetes, especially among the growing geriatric population is creating a positive outlook for the market. In line with this, blood glucose test strips are widely used to test sugar levels regularly at home, while eliminating the need to visit a diagnostic laboratory, which is supporting the market growth. Additionally, the widespread product adoption among type-2 diabetic patients due to the easy availability of glucometers, convenient handling, and the level of accuracy provided by the machine are favoring the market growth. Moreover, the demand and online sales for blood glucose monitoring devices and consumables, such as test strips significantly surged during the coronavirus disease (COVID-19) pandemic. This can be attributed to the increasing need to continuously monitor sugar levels in patients and commoners both as a precautionary measure and to record post-infection symptoms, which, in turn, is augmenting the market growth. Other factors, including extensive research and development (R&D) activities in the field of biomedical engineering, evolving lifestyles and eating habits, and the implementation of various government initiatives focusing on educating the masses regarding diabetes and its preventive measures, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood glucose test strips market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, technology, distribution channel and end user.
Breakup by Type:
Breakup by Technology:
Breakup by Distribution Channel:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 77 Elektronika Kft., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings), B. Braun Melsungen Aktiengesellschaft, Bioland Technology Ltd., Bionime Corporation, BTNX Inc., Microlife Corporation (Midas Company Limited), Norditalia Group S.R.L., Rossmax International Ltd. and Unistrip Technologies LLC.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Technology, Distribution Channel, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||77 Elektronika Kft., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings), B. Braun Melsungen Aktiengesellschaft, Bioland Technology Ltd., Bionime Corporation, BTNX Inc., Microlife Corporation (Midas Company Limited), Norditalia Group S.R.L., Rossmax International Ltd. and Unistrip Technologies LLC.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at